Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 274

Sort by

Sort Order Select

Journal Articles

Use of Post-Transplant Cyclophosphamide in One-Antigen Mismatched Unrelated Donor Transplantation Results in Similar Transplant Outcomes Than Haploidentical Hransplantation: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the EBMT

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-137099

Published: 2020

Journal Articles

Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia

Ohad Benjamini, Avichai Shimoni, MD, Michal Besser, PhD, Noga Shem-Tov, MD, Ivetta Danylesko, MD, Ronit Yerushalmi, MD, Drorit Grizim Merkel, MD, Tamar Tadmor, MD, David Lavie, MD, Riva Fineman, MD, Elad Jacobi, MD, Arnon Nagler, MD, Abraham Avigdor, MD

Blood (2020) 136 (Supplement 1): 40.

https://doi.org/10.1182/blood-2020-138904

Published: 2020

Journal Articles

Outcomes of Allogeneic Hematopoietic Cell Transplantation with Cord Blood Versus Mismatched Unrelated Donor with Post-Transplant Cyclophosphamide in Acute Myeloid Leukemia: An Analysis from the ALWP of the EBMT

Bhagirathbhai Dholaria, MBBS, Myriam Labopin, MD, Jaime Sanz Caballer, MD PhD, Annalisa Ruggeri, MD, Jan J. Cornelissen, MD PhD, Hélène Labussière-Wallet, Didier Blaise, MD, Edouard Forcade, MD, Patrice Chevallier, MD PhD, Anna Grassi, MD, Ludmila S Zubarovskaya, MD PhD professor, Jurgen H.E. Kuball, MD PhD, Patrice Ceballos, MD PhD, Fabio Ciceri, MD, Bipin N. Savani, MD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-139362

Published: 2020

Journal Articles

Comparison of Reduced Intensity Conditioning - Allogeneic HCT and Autologous HCT for Elderly Patients with Acute Lymphoblastic Leukemia. an Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Sebastian Giebel, Sr., Myriam Labopin, MD, Mohamed Houhou, Denis Caillot, Jürgen Finke, Sr., MD PhD, Didier Blaise, MD, Nathalie Fegueux, Mark Edward Ethell, MD, Jan J. Cornelissen, MD PhD, Edouard Forcade, MD PhD, Ibrahim Yakoub-Agha, Federico Lussana, MD, Johan Maertens, Jean-Henri Bourhis, Pavel Jindra, MD PhD, Norbert Claude Gorin, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-140328

Published: 2020

Journal Articles

Personalized Risk-Profiling for Acute Leukemia Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Acute Leukemia Working Party of the EBMT

Joshua A Fein, MD, Roni Shouval, MD PhD, Myriam Labopin, MD, Fabio Ciceri, MD, Emanuele Angelucci, MD, Didier Blaise, MD, Johanna Tischer, William Arcese, MD PhD, Yener Koc, MD, Benedetto Bruno, MD, Jose L. Diez-Martin, MD PhD, Stella Santarone, MD, Simona Sica, MD PhD, Jurjen Versluis, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-139519

Published: 2020

Journal Articles

Reduced Intensity Vs. Non-Myeloablative Conditioning Regimens for Haploidentical Transplantation in Complete Remission Acute Myeloid Leukemia: A Study from the ALWP of the EBMT

Raynier Devillier, Jacques-Emmanuel Galimard, Myriam Labopin, MD, Didier Blaise, MD, Emanuele Angelucci, Luca Castagna, Jiri Pavlu, MDMRCP,FRCPath, Gerard Socie, MDPhD, Massimo Martino, Friedrich Stoelzel, PD, MD, Gesine Bug, Yves Chalandon, MD, Benedetto Bruno, MD, Victoria Potter, MBBS, BSc, FRACP, FRCPA, Eolia Brissot, MDPhD, Bipin N. Savani, MD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2020) 136 (Supplement 1): 9.

https://doi.org/10.1182/blood-2020-140657

Published: 2020

Journal Articles

Evaluating Outcomes of Adult Patients with Acute Lymphoblastic Leukemia Treated on the GMALL Protocol

Danielle Fredman, Yulia Volchek, MD, Gabriel Heering, Keren Shichrur, PhD, Ronit Yerushalmi, MD, Noga Shem-Tov, MD, Elena Ribakovsky, MD, Avichai Shimoni, MD, Abraham Avigdor, MD, Arnon Nagler, MD, Jonathan Canaani, MD

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-134771

Published: 2020

Journal Articles

A Phase II Study of Bisantrene in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Jonathan Canaani, MD, Ivetta Danilesko, MD, Noga Shem-Tov, MD, Maya Zlotnick, MD, Kira Lozinsky, Ohad Benjamini, Ronit Yerushalmi, MD, Meital Nagar, PhD, Chen Dor, PhD, Avichai Shimoni, MD, Abraham Avigdor, MD, Arnon Nagler, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-135947

Published: 2020

Journal Articles

CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma: a Safety and Efficacy Study

Yongxian Hu, MD, Yanlei Zhang, Houli Zhao, MD, Yiyun Wang, Arnon Nagler, MD, Alex Hong Chang, He Huang, MD PhD

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-143239

Published: 2020

Journal Articles

A Novel Inflammatory Index Is Sufficient to Identify Hemophagocytic Lymphohistiocytosis in Adult Patients with Hematologic Malignancies

Adi Zoref-Lorenz, MD, Jun Murakami, MD PhD, Liron Hofstetter, MD, Swaminathan P Iyer, MD, Ahmad S. Alotaibi, MD, Peter Miller, MDPhD, Elad Guber, MD, Shiri Weinstein, MD, Joanne Yacobovich, MD MPH, Sarah Nikiforow, MD PhD, Benjamin L. Ebert, MDPhD, Oren Pasvolsky, MD, Pia Raanani, MD, Arnon Nagler, MD, Nancy Berliner, MD, Naval Daver, MD, Martin H Ellis, Michael B. Jordan, MD

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-143011

Published: 2020

Journal Articles

Assessment By MRI T2*of Iron Accumulation and Removal in Transfusion Dependent MDS Patients

Drorit Grizim Merkel, MD, Abraham Avigdor, MD, Arnon Nagler, MD MSc, Ohad Benjamini, MD, Yaron Davidovitz, MD, Orly Goitein, MD

Blood (2019) 134 (Supplement_1): 5432.

https://doi.org/10.1182/blood-2019-125279

Published: 2019

Journal Articles

Copanlisib, a PI3K Inhibitor, Demonstrates a Favorable Long-Term Safety Profile in a Pooled Analysis of Patients with Hematologic Malignancies

Pier Luigi Zinzani, MD, Armando Santoro, Luigina Mollica, MD FRCPC, PhD, Sirpa Leppä, MD PhD, George A Follows, MD PhD, Georg Lenz, MD, Won Seog Kim, MD PhD, Arnon Nagler, MD MSc, Panayiotis Panayiotidis, MD, Judit Demeter, MD PhD Dr. Sci, Franck Morschhauser, MD, Javier Munoz, MD MS, FACP, Ashok Miriyala, MD, Alice Benson, PhD, Jose Garcia-Vargas, MD, Barrett H Childs, MD, Martin Dreyling, MD

Blood (2019) 134 (Supplement_1): 4009.

https://doi.org/10.1182/blood-2019-131779

Published: 2019

Journal Articles

Comparison of Mycophenolate Mofetil and a Calcineurin Inhibitor Versus Calcineurin Inhibitor Based Graft-Versus-Host-Disease Prophylaxis for Matched Unrelated Donor Transplant for Acute Myeloid Leukemia. a Study from the ALWP of the EBMT

Annalisa Paviglianiti, MD, Myriam Labopin, MD, Didier Blaise, MD PhD, Gerard Socie, MD PhD, Claude-Eric Bulabois, MD, Celestine Simand, MD, Nathalie Fegueux, MD, Armin Gerbitz, MD, Gaëlle Guillerm, MD, Johan Maertens, Patrice Chevallier, MD, Anne Huynh, MD, Pascal Turlure, MD, Eric Deconinck, MD PhD, Edouard Forcade, MD, Arnon Nagler, MD MSc, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 4548.

https://doi.org/10.1182/blood-2019-122251

Published: 2019

Journal Articles

Early Organ Toxicity Following Allogeneic Hematopoietic Stem Cell Transplantation Differs By Conditioning Regimen

Joshua A Fein, MD, Avichai Shimoni, MD, Ivetta Danylesko, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Guy Chowers, MD, Zachary Cohen, Arnon Nagler, MD MSc, Roni Shouval

Blood (2019) 134 (Supplement_1): 4489.

https://doi.org/10.1182/blood-2019-126325

Published: 2019

Journal Articles

Maintaining the Cellular Anti-Viral and Anti-Leukemic Activities in GvHD Patients Undergoing Extracorporeal Photophoresis Therapy

Ruben A. Gößmann, Lei Wang, MD, Ming Ni, Mingya Yang, MD, Thomas Luft, Ute Hegenbart, MD, Stefan O. Schönland, MD, Patrick Wuchter, MD, Volker Eckstein, William Hermann Krüger, MD PhD, Ronit Yerushalmi, MD, Katia Beider, Arnon Nagler, MD MSc, Carsten Müller-Tidow, MD, Peter Dreger, Michael Schmitt, MD, Anita Schmitt, MD

Blood (2019) 134 (Supplement_1): 3287.

https://doi.org/10.1182/blood-2019-125049

Published: 2019

Journal Articles

Upregulation of Senescent/Exhausted Phenotype of CAR T Cells and Induction of Both Treg and Myeloid Suppressive Cells Correlate with Reduced Response to CAR T Cell Therapy in Relapsed/Refractory B Cell Malignancies

Katia Beider, Michal J Besser, PhD, Jacob Schachter, MD, Ania Hava Grushchenko-Polaq, Valeria Voevoda, Idit Wolf, Olga Ostrovsky, PhD, Elad Jacoby, MD, Avichai Shimoni, MD, Arnon Nagler, MD MSc

Blood (2019) 134 (Supplement_1): 3234.

https://doi.org/10.1182/blood-2019-128068

Published: 2019

Journal Articles

Oral Mucositis Is Associated with Distinctive Patterns of Oral Microbiota Injury in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Roni Shouval, Adi Eshel, MSc, Ivetta Danylesko, Bar Dubovski, Joshua A Fein, MD, Shalev Fried, Mika Geva, MD, Elizaveta Kouniavsky, Amir A Kuperman, MD MSc, Yoram Louzoun, PhD, Omry Koren, PhD, Arnon Nagler, MD MSc

Blood (2019) 134 (Supplement_1): 3265.

https://doi.org/10.1182/blood-2019-125433

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Francesco Saraceni, Myriam Labopin, MD, Riitta Niittyvuopio, Gerard Socie, MD PhD, Nicolaus Kröger, Edouard Forcade, MD, Paul V Browne, MB,FRCPath, Péter Reményi, Jan J Cornelissen, MD PhD, Stephen Robinson, MBBS, PhD BSc, Ibrahim Yakoub-Agha, MD PhD, Thierry Lamy, PhD MD, Eolia Brissot, MD PhD, Bipin N. Savani, MD, Arnon Nagler, MD MSc, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 3327.

https://doi.org/10.1182/blood-2019-127810

Published: 2019

Journal Articles

Post-Transplant Cyclophosphamide after Matched Sibling, Unrelated and Haploidentical Donor Transplants in Patients with Acute Myeloid Leukemia, a Comparative Study of the ALWP EBMT

Jaime Sanz, MD PhD, Jaques-Emmanuel Galimard, Boris V Afanasyev, MD PhD professor, Emanuele Angelucci, MD, Fabio Ciceri, MD, Didier Blaise, MD PhD, Jan J Cornelissen, MD PhD, Ellen Meijer, MD PhD, José Luis Díez-Martín, MD PhD, Yener Koc, MD, Montserrat Rovira, Luca Castagna, MD, Bipin N. Savani, MD, Annalisa Ruggeri, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc

Blood (2019) 134 (Supplement_1): 3274.

https://doi.org/10.1182/blood-2019-125859

Published: 2019

Journal Articles

Maintenance 5-Azactidine May Improve Outcomes after Allogeneic Stem-Cell Transplantation in High-Risk AML and MDS Patients

Ivetta Danylesko, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Arnon Nagler, MD MSc, Avichai Shimoni, MD

Blood (2019) 134 (Supplement_1): 3302.

https://doi.org/10.1182/blood-2019-129966

Published: 2019

NARROW

Use of Post-Transplant Cyclophosphamide in One-Antigen Mismatched Unrelated Donor Transplantation Results in Similar Transplant Outcomes Than Haploidentical Hransplantation: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the EBMT

Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia

Outcomes of Allogeneic Hematopoietic Cell Transplantation with Cord Blood Versus Mismatched Unrelated Donor with Post-Transplant Cyclophosphamide in Acute Myeloid Leukemia: An Analysis from the ALWP of the EBMT

Comparison of Reduced Intensity Conditioning - Allogeneic HCT and Autologous HCT for Elderly Patients with Acute Lymphoblastic Leukemia. an Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Personalized Risk-Profiling for Acute Leukemia Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Study on Behalf of the Acute Leukemia Working Party of the EBMT

Reduced Intensity Vs. Non-Myeloablative Conditioning Regimens for Haploidentical Transplantation in Complete Remission Acute Myeloid Leukemia: A Study from the ALWP of the EBMT

Evaluating Outcomes of Adult Patients with Acute Lymphoblastic Leukemia Treated on the GMALL Protocol

A Phase II Study of Bisantrene in Patients with Relapsed/Refractory Acute Myeloid Leukemia

CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma: a Safety and Efficacy Study

A Novel Inflammatory Index Is Sufficient to Identify Hemophagocytic Lymphohistiocytosis in Adult Patients with Hematologic Malignancies

Assessment By MRI T2*of Iron Accumulation and Removal in Transfusion Dependent MDS Patients

Copanlisib, a PI3K Inhibitor, Demonstrates a Favorable Long-Term Safety Profile in a Pooled Analysis of Patients with Hematologic Malignancies

Comparison of Mycophenolate Mofetil and a Calcineurin Inhibitor Versus Calcineurin Inhibitor Based Graft-Versus-Host-Disease Prophylaxis for Matched Unrelated Donor Transplant for Acute Myeloid Leukemia. a Study from the ALWP of the EBMT

Early Organ Toxicity Following Allogeneic Hematopoietic Stem Cell Transplantation Differs By Conditioning Regimen

Maintaining the Cellular Anti-Viral and Anti-Leukemic Activities in GvHD Patients Undergoing Extracorporeal Photophoresis Therapy

Upregulation of Senescent/Exhausted Phenotype of CAR T Cells and Induction of Both Treg and Myeloid Suppressive Cells Correlate with Reduced Response to CAR T Cell Therapy in Relapsed/Refractory B Cell Malignancies

Oral Mucositis Is Associated with Distinctive Patterns of Oral Microbiota Injury in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Post-Transplant Cyclophosphamide after Matched Sibling, Unrelated and Haploidentical Donor Transplants in Patients with Acute Myeloid Leukemia, a Comparative Study of the ALWP EBMT

Maintenance 5-Azactidine May Improve Outcomes after Allogeneic Stem-Cell Transplantation in High-Risk AML and MDS Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only